Scholars Central

Conference abstractPublished 7 Dec 2015

The Association between Interleukin-28B Gene Single Nucleotide Polymorphism (rs8099917) and the Response to Pegylated Interferon and Ribavirin Combined Therapy in Egyptian Patients Chronically Infected with Hepatitis C V

Authors: Salwa H Gomaa, Mona H Kandil, Ahmed Tork, Hanan M Mostafa

Department of Chemical Pathology; Department of internal medicine. Medical Research Institute, Alexandria University, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Egypt has the highest prevalence of Hepatitis C virus (HCV) infection in the world, estimated nationally to infect 14.7% of the population.The standard of care treatment consists of a pegylated interferon (PEG IFN) and ribavirin (RBV) combination. It is valuable to predict an individual’s response to peg-IFN/RBV before their use in treatment to avoid side effects, to choose the appropriate treatment for the appropriate patient as well as to reduce the treatment cost.Single nucleotide polymorphisms (SNPs) near the interferon-lambda3-encoding IL28B gene may affect sustained viral response . The present work aimed at studying the association between the interleukin 28-B T/G single nucleotide polymorphism (rs8099917) and early virological response to combined peg-IFN/RBV therapy. Ninety nine chronic HCV Egyptian patients receiving combined peg-IFN/RBV were included and subdivided into forty nine patients proved to be responders and fifty patients proved to be non-responders based on their early virological response.Genotyping of interleukin 28B single nucleotide gene polymorphism rs8099917 was done using allelic discrimination Real âÂ?Â?Time PCR with dual labeled fluorogenic TaqMan minor groove binder probes. Nonresponders had a significant higher frequency of the homo-mutant genotype GG than responders, a higher hetero-mutant genotype âÂ?Â?TGâÂ? than responders and a lower Homo-wild genotype âÂ?Â?TTâÂ? than responders (p=0.01842) .This resulted in an overall Odds ratio of 2.048 (95% CI: 1.067 to 3.929). From these results it could be concluded that the mutant allele âÂ?Â?GâÂ? of the rs8099917 SNP of IL28B was associated with a statistically significant increased risk of non-response to peg-IFN/RBV therapy among the studied Egyptian CHC patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Antivirals & Antiretrovirals
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Salwa H Gomaa”
  • BylineArticles whose byline prints “Mona H Kandil”
  • BylineArticles whose byline prints “Ahmed Tork”
  • BylineArticles whose byline prints “Hanan M Mostafa”